Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Olive

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Investigation|June 15, 2011
Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblastsKan Cao, Cecilia D Blair, Dina A Faddah, et al.
Plos One|September 15, 2011
Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonatesRegina Bökenkamp, Vered Raz, Andrea Venema, et al.
Circulation Research|June 11, 2016
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood DiseasesRay F Ebert, Narasimhan S Danthi, Marc F Charette, et al.
The Journal of Clinical Investigation|May 10, 2008
p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in miceMichelle Olive, Jason A Mellad, Leilani E Beltran, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defectValerie L R M Verstraeten, Lana A Peckham, Michelle Olive, et al.
Circulation Research|September 22, 2007
Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxideAndrea L True, Michelle Olive, Manfred Boehm, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse modelBrian C Capell, Michelle Olive, Michael R Erdos, et al.
Circulation|July 18, 2018
Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute WorkshopIra J Goldberg, Karen Reue, Nada A Abumrad, et al.
Journal of the American College of Cardiology|January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisSotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2010
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of agingMichelle Olive, Ingrid Harten, Richard Mitchell, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Investigation|June 15, 2011
Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblastsKan Cao, Cecilia D Blair, Dina A Faddah, et al.
Plos One|September 15, 2011
Differential temporal and spatial progerin expression during closure of the ductus arteriosus in neonatesRegina Bökenkamp, Vered Raz, Andrea Venema, et al.
Circulation Research|June 11, 2016
The NHLBI SMARTT Program: A Novel Approach to Facilitate Translational Research for Heart, Lung and Blood DiseasesRay F Ebert, Narasimhan S Danthi, Marc F Charette, et al.
The Journal of Clinical Investigation|May 10, 2008
p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in miceMichelle Olive, Jason A Mellad, Leilani E Beltran, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2011
Protein farnesylation inhibitors cause donut-shaped cell nuclei attributable to a centrosome separation defectValerie L R M Verstraeten, Lana A Peckham, Michelle Olive, et al.
Circulation Research|September 22, 2007
Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxideAndrea L True, Michelle Olive, Manfred Boehm, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse modelBrian C Capell, Michelle Olive, Michael R Erdos, et al.
Circulation|July 18, 2018
Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute WorkshopIra J Goldberg, Karen Reue, Nada A Abumrad, et al.
Journal of the American College of Cardiology|January 13, 2018
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic StenosisSotirios Tsimikas, Sergio Fazio, Keith C Ferdinand, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2010
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of agingMichelle Olive, Ingrid Harten, Richard Mitchell, et al.
Pageof 3